Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Consolidated Unit Volume & Product Mix Growth YoY by Quarter
Consolidated Unit Volume & Product Mix Growth YoY (%) (%)
Stryker Consolidated Unit Volume & Product Mix Growth YoY: 7.6% in Q3 2026, down 1.5 pts from a year earlier.
Latest, Q3 2026
7.6%
Period ended Sep 30, 2026
Change on a year earlier
-1.5 pts
9.1% in Q3 2025
History
14 quarters
Since Q1 2022
Sources
14
Documents cited below
Where the Q3 2026 figure comes from
“Net sales in constant currency increased by 7.6% from increased unit volume and 0.1% due to higher prices.”
Reported in Stryker Form 10-Q & Form 10-K MD&A (Verbatim Constant-Currency Volume/Mix Contribution).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Stryker Consolidated Unit Volume & Product Mix Growth YoY (%), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/core-cons-unit-vol
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.